Vismodegib for the treatment of radiation-induced basal cell carcinoma – a case report and brief literature study
Vismodegib is playing an increasing role in the treatment of locally advanced or metastatic basal cell carcinoma (BCC) that is not a candidate for surgery or radiotherapy, and also in radiation-induced BCC. A 22-year-old man with a history of Hodgkin lymphoma, nodular sclerosis stage IIA, from Octob...
Main Authors: | Concetta Laliscia, Davide Baldaccini, Andrea Antonuzzo, Fabiola Paiar |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2019-12-01
|
Series: | Contemporary Oncology |
Subjects: | |
Online Access: | https://www.termedia.pl/Vismodegib-for-the-treatment-of-radiation-induced-basal-cell-carcinoma-a-case-report-and-brief-literature-study,3,39555,1,1.html |
Similar Items
-
Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib
by: Maxwell G. Su, et al.
Published: (2020-09-01) -
Vismodegib: The first drug approved for advanced and metastatic basal cell carcinoma
by: A K Dubey, et al.
Published: (2013-01-01) -
Vismodegib dose reduction effective when combined with itraconazole for the treatment of advanced basal cell carcinoma
by: Jaeyoung Yoon, MD, PhD
Published: (2021-01-01) -
Vismodegib and orbital excision for treating locally advanced basal cell carcinoma
by: Hogarty DT, et al.
Published: (2018-07-01) -
Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy
by: Apalla Z, et al.
Published: (2017-05-01)